Voltage-gated ion channels in cancer cell proliferation

VR Rao, M Perez-Neut, S Kaja, S Gentile - Cancers, 2015 - mdpi.com
Changes of the electrical charges across the surface cell membrane are absolutely
necessary to maintain cellular homeostasis in physiological as well as in pathological …

HERG channel and cancer: a mechanistic review of carcinogenic processes and therapeutic potential

S He, MT Moutaoufik, S Islam, A Persad, A Wu… - … et Biophysica Acta (BBA …, 2020 - Elsevier
The human ether-à-go-go related gene (HERG) encodes the alpha subunit of Kv11. 1, which
is a voltage-gated K+ channel protein mainly expressed in heart and brain tissue. HERG …

Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling

EK Breuer, D Fukushiro-Lopes, A Dalheim… - Cell death & …, 2019 - nature.com
Potassium ion channels are critical in the regulation of cell motility. The acquisition of cell
motility is an essential parameter of cancer metastasis. However, the role of K+ channels in …

[HTML][HTML] Use of genetically encoded, light-gated ion translocators to control tumorigenesis

BT Chernet, DS Adams, M Lobikin, M Levin - Oncotarget, 2016 - ncbi.nlm.nih.gov
It has long been known that the resting potential of tumor cells is depolarized relative to their
normal counterparts. More recent work has provided evidence that resting potential is not …

Ion channel drugs suppress cancer phenotype in NG108-15 and U87 cells: toward novel electroceuticals for glioblastoma

J Mathews, F Kuchling, D Baez-Nieto, M Diberardinis… - Cancers, 2022 - mdpi.com
Simple Summary Glioblastoma is a rapidly progressing brain cancer that is very difficult to
treat. Given that many aspects of cell and tissue behavior are controlled by electric signaling …

Blocking xCT and PI3K/Akt pathway synergized with DNA damage of Riluzole-Pt (IV) prodrugs for cancer treatment

Z Li, X Qiao, XM Liu, SH Shi, JY Xu - European Journal of Medicinal …, 2023 - Elsevier
Cancer treatment requires the participation of multiple targets/pathways, and single
approach is hard to effectively curb the proliferation and metastasis of carcinoma cells. In …

Bioelectric pharmacology of cancer: a systematic review of ion channel drugs affecting the cancer phenotype

K Kofman, M Levin - Progress in Biophysics and Molecular Biology, 2024 - Elsevier
Cancer is a pernicious and pressing medical problem; moreover, it is a failure of
multicellular morphogenesis that sheds much light on evolutionary developmental biology …

[HTML][HTML] Preclinical study of a Kv11. 1 potassium channel activator as antineoplastic approach for breast cancer

DF Fukushiro-Lopes, AD Hegel, V Rao, D Wyatt… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Potassium ion (K+) channels have been recently found to play a critical role in cancer
biology. Despite that pharmacologic manipulation of ion channels is recognized as an …

Pharmacological activation of potassium channel Kv11. 1 with Ns1643 attenuates triple negative breast cancer cell migration by promoting the dephosphorylation of …

Y Jiang, V Senyuk, K Ma, H Chen, X Qin, S Li, Y Liu… - Cells, 2022 - mdpi.com
The prevention of metastasis is a central goal of cancer therapy. Caveolin-1 (Cav-1) is a
structural membrane and scaffolding protein shown to be a key regulator of late-stage breast …

HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway

H Wang, X Yang, Y Guo, L Shui, S Li, Y Bai… - Journal of Experimental …, 2019 - Springer
Background The human ether a-go-go-related gene 1 (HERG1) is involved in tumor
progression; however, its role in esophageal squamous cell carcinoma (ESCC) is not well …